Found 11 matching trials
Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease
PHASE1A Phase 1 study designed to evaluate imaging characteristics of flortaucipi...
Location
Multiple Locations
Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects
EARLY_PHASE1This early phase 1 study explored the brain uptake, retention, and safety o...
Augmenting Flortaucipir Dosimetry Estimates
PHASE1This study will obtain data from urine in subjects administered flortaucipi...
Location
Molecular NeuroImaging
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
PHASE1This study will evaluate flortaucipir for brain imaging of tau in subjects ...
Location
University of Alabama at Birmingham
Tau Imaging in Professional Fighters
PHASE1Subjects enrolled in the Professional Fighters Brain Health Study (PFBHS) w...
Location
Cleveland Clinic Lou Ruvo Center for Brain Health
Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease
PHASE1The purpose of this study is to compare/harmonize cross-sectional and longi...
Status
Active Not Recruiting
Location
Lawrence Berkeley National Laboratory
Alzheimer's Disease Neuroimaging Initiative 4
N/AThe Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4) is a non-randomiz...
Status
Enrolling By Invitation
Location
University of Alabama at Birmingham
Flortaucipir PET Imaging in Subjects With FTD
PHASE1This study is designed to assess the usefulness of flortaucipir in Positron...
Location
Movement Disorder Center, UCSD
Flortaucipir 18F PET Imaging in BIOCARD Study
PHASE1This study is designed to assess the imaging characteristics of Flortaucipi...
Location
Johns Hopkins Hospital
A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects
PHASE1This study will test if two flortaucipir PET scans up to 4 weeks apart in h...